Aldeyra Therapeutics, Inc.
ALDX
Revenue
0.00
0.000.00%
-Assets
104.61M
▼-12.71M▼-10.84%
3 Months ChangeLiabilities
33.60M
▲1.38M▲4.28%
3 Months ChangeFree Cash Flow
-9.44M
▲3.45M▲26.73%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-03
Form 8-K
ID: 0001213900-24-084844
2024-10-02
Form 8-K
ID: 0001193125-24-231158
2024-09-03
Form 8-K
ID: 0001193125-24-211645
2024-08-08
Form 8-K
ID: 0001213900-24-066327
2024-08-01
Form 8-K
ID: 0001193125-24-191518
2024-08-01
Form 10-Q
ID: 0000950170-24-089238
2024-06-20
Form 8-K
ID: 0001213900-24-054003
2024-06-13
Form 8-K
ID: 0001213900-24-052234
2024-06-07
Form 8-K
ID: 0001193125-24-157328
2024-05-02
Form 10-Q
ID: 0000950170-24-052056